PHI with Schmidt's syndrome
How does this condition affect your private health insurance?
Schmidt-Syndrom, also known as Autoimmune Polyendocrine Syndrome Type 2 (APS-2), is a rare autoimmune disorder characterized by the simultaneous or sequential failure of multiple endocrine glands. It typically involves Addison's disease (adrenal insufficiency) combined with autoimmune thyroid disease (Hashimoto's or Graves' disease) and/or Type 1 diabetes mellitus. The immune system mistakenly attacks and destroys these vital glands. Symptoms are diverse, reflecting the affected organs, and can include fatigue, weight loss, muscle weakness, and metabolic disturbances. Diagnosis relies on specific hormone and autoantibody tests. Management involves lifelong hormone replacement therapy for the deficient glands to prevent life-threatening crises.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 50%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months for initial symptom onset; acute crises (e.g., adrenal crisis) can be sudden.
Duration of Illness (Lifetime)
Chronic, lifelong management is required.
Cost of Treatment (Initial)
Moderate to high, including extensive diagnostic testing, initial hospitalization (if in crisis), and stabilization with hormone replacement.
Cost of Treatment (Lifetime)
High, due to lifelong hormone replacement therapy, regular monitoring (blood tests, specialist visits), and management of associated conditions and potential complications.
Mortality Rate
Low with timely diagnosis and consistent, appropriate treatment. Significantly higher if undiagnosed or improperly managed, particularly during an adrenal crisis.
Risk of Secondary Damages
Moderate to high without proper management (e.g., metabolic imbalances, cardiovascular complications, severe infections due to adrenal insufficiency). With treatment, risks are reduced but complications from individual autoimmune components can still occur.
Probability of Full Recovery
Very low; it is a chronic autoimmune condition requiring lifelong hormone replacement and management. Complete reversal of autoimmune damage is generally not possible.
Underlying Disease Risk
High, as the syndrome is defined by the co-occurrence of multiple autoimmune endocrine diseases (e.g., Addison's disease, Type 1 diabetes, autoimmune thyroid disease). When one component is diagnosed, there is a high probability of other components being present or developing later.